UnknownNot Applicable

Inert Gas Rebreathing in Ventilated Patients

Germany50 participantsStarted 2013-03

Plain-language summary

Measuring hemodynamic parameters in ventilated patients is important yet still complicated to perform. Inert gas rebreathing (IGR) showed promising results when being compared to other invasive as well as non-invasive techniques for the measurement of cardiac output. The aim of our study is to evaluate the feasibility of IGR in ventilated patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 18 - 80 years * mechanically ventilated patient * existing PiCCO arterial line Exclusion Criteria: * FiO2 \> 60% (fraction of inspired oxygen) * PEEP \> 10 mmHg (positive end-expiratory pressure) * SO2 \< 90% (oxygen saturation ) * Systolic blood pressure \< 90 mmHg * Heart rate \> 150 bpm * APRV (airway pressure release ventilation) * ICD (implantable cardioverter defibrillator) / pace maker * \[ Anaesthetic Conserving Device (Anaconda) \]

What they're measuring

cardiac output

Timeframe: 1 day

Trial details

NCT IDNCT01891253

SponsorUniversitätsmedizin Mannheim

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12

View on ClinicalTrials.gov More Sepsis trials